Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab in Combination With ICE as Salvage Therapy in Relapsed DLBCL
NCT00980304Phase 2Unknown
- Sponsor
- Shanghai Jiao Tong University School of Medicine
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 2 trial of rituximab in diffuse large B-cell lymphoma (DLBCL), sponsored by Shanghai Jiao Tong University School of Medicine. Status: unknown.
02
Drugs
rituximab
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT00980304.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00980304.